Go
All Publishers
24-7 Press Release Newswire
Chainwire
EZ Newswire
GlobeNewswire
Get Featured
Investor Brand Network
iCrowdNewswire
Prodigy Press Wire
KoreWire
Law Firm Newswire
Media OutReach
MoneyShow Newswire
NewsDirect
Pinion Newswire
Press Advantage
PR Newswire
Press Services
Syndication Cloud
StatePoint Media
Entrata Collaborates with OpenAI to Define the Future of Autonomous Property Management
GlobeNewswire
Today at 11:00pm UTC
SK Telecom and NVIDIA Build AI Infrastructure to Power Korea’s AI Innovation
GlobeNewswire
Today at 11:00pm UTC
NAVER Expands AI Infrastructure With NVIDIA to Serve Surging Global AI Demand
GlobeNewswire
Today at 11:00pm UTC
NVIDIA and SK hynix Announce Multiyear Technology Partnership to Advance Memory for AI Factories
GlobeNewswire
Today at 11:00pm UTC
Sportradar Group AG (SRAD) Investors: July 17, 2026, Deadline in Securities Fraud Class Action Lawsuit Filed by Kessler Topaz Meltzer &...
PR Newswire
Today at 10:52pm UTC
VolitionRx Announces Pricing of $4.6 Million Public Offering
PR Newswire
Today at 10:30pm UTC
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class...
GlobeNewswire
Today at 10:13pm UTC
He Predicted Gold at $5,000. Now He Says This $2 Stock Could Be Even Bigger.
GlobeNewswire
Today at 10:00pm UTC
MEDP DEADLINE TOMORROW: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Medpace Holdings, Inc. Investors to Secure Counsel Before Important June...
GlobeNewswire
Today at 9:55pm UTC
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
PR Newswire
Today at 9:30pm UTC
Novo Nordisk's CagriSema 2.4 mg / 2.4 mg demonstrated significant reduction in HbA1c and weight across multiple studies in the REIMAGINE...
PR Newswire
Today at 9:30pm UTC
FCM marks 125 years as municipal leaders gather in Edmonton
PR Newswire
Today at 9:12pm UTC
Diasome Presents Phase 2b Data Demonstrating HDV™-Insulin Lispro Maintains Glycemic Control While Reducing Hypoglycemia in Adults with Type...
GlobeNewswire
Today at 9:00pm UTC
Monday, June 8, 2026
PR Newswire
Today at 9:00pm UTC
Lipid-Lowering Medications Demonstrate Cardiometabolic Benefits in Populations with High-Risk Diabetes
PR Newswire
Today at 8:45pm UTC
AMGEN PRESENTS NEW DATA ACROSS ITS CARDIOMETABOLIC PORTFOLIO AT AMERICAN DIABETES ASSOCIATION 86TH SCIENTIFIC SESSIONS
PR Newswire
Today at 8:45pm UTC
GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders
GlobeNewswire
Today at 7:40pm UTC
Photo Scanning Services 2026 - iMemories Launched Photo Scanning Services for Families Across the USA
GlobeNewswire
Today at 7:30pm UTC
Head-to-head Study Validates the Clinical Advantage of New-generation Biased GLP-1: Ecnoglutide Delivers 35% Greater Weight Loss than...
PR Newswire
Today at 6:30pm UTC
Boehringer Ingelheim’s survodutide Phase III trial showed targeted 34% visceral and 63% liver fat reduction, while minimizing lean mass loss...
GlobeNewswire
Today at 6:30pm UTC
<
1
2
3
4
5
6
...
19
20
>
Skip to main content
About Us
Contact Us
Advertise
Subscribe
The Local's LIST
Community Calendar
Made in Iredell
Inspiring Iredell
On The Farm
Preserving Our Heritage
Public Notices
Sponsored Content
Submit an Event
List Your Business
Login/Join
Search
Search
The Local's LIST
Community Calendar
Made in Iredell
Inspiring Iredell
On The Farm
Preserving Our Heritage
Public Notices